ストックスクリーナーアプリを入手
23.13
1.36%
-0.32
プレマーケット:
23.28
0.15
+0.65%
前日終値:
$23.45
開ける：
$23.56
24時間の取引高:
1.44M
Relative Volume:
0.81
時価総額：
$1.42B
収益：
$796.00M
当期純損益:
$-136.49M
株価収益率:
-11.07
EPS:
-2.09
ネットキャッシュフロー:
$-64.24M
1週間 パフォーマンス:
+8.49%
1か月 パフォーマンス:
+35.58%
6か月 パフォーマンス:
-22.04%
1年 パフォーマンス:
-47.35%
1日の値動き範囲:
$23.05
$23.56
1週間の範囲:
$21.28
$24.00
52週間の値動き範囲:
$15.75
$53.69
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
名前
Tandem Diabetes Care Inc
セクター
電話
858-366-6900
住所
12400 HIGH BLUFF DRIVE, San Diego, CA
TNDM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
23.13 | 1.42B | 796.00M | -136.49M | -64.24M | -2.09 |
|
ABT
Abbott Laboratories
|
129.05 | 231.50B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.95 | 154.04B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
387.53 | 144.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
85.11 | 105.58B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.50 | 43.95B | 5.54B | 4.18B | 623.10M | 7.00 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-10 | 開始されました | Mizuho | Neutral |
| 2025-03-05 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-04 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-03-03 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2025-02-28 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2024-12-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-06 | 開始されました | Bernstein | Outperform |
| 2024-10-04 | 開始されました | Goldman | Neutral |
| 2024-10-02 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-08-22 | 開始されました | Morgan Stanley | Equal-Weight |
| 2024-08-08 | 開始されました | Canaccord Genuity | Buy |
| 2024-05-30 | 開始されました | Redburn Atlantic | Buy |
| 2024-05-22 | アップグレード | Citigroup | Neutral → Buy |
| 2024-04-29 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | アップグレード | Stifel | Hold → Buy |
| 2023-08-04 | ダウングレード | Citigroup | Buy → Neutral |
| 2023-05-05 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-04-24 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | 開始されました | UBS | Neutral |
| 2023-01-26 | 開始されました | Wolfe Research | Peer Perform |
| 2022-11-15 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-08-09 | ダウングレード | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | 再開されました | BofA Securities | Neutral |
| 2022-01-19 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | 再開されました | Cowen | Outperform |
| 2021-05-25 | 開始されました | Barclays | Underweight |
| 2020-12-15 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | 開始されました | Wells Fargo | Overweight |
| 2020-07-31 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-07-06 | アップグレード | Citigroup | Neutral → Buy |
| 2020-06-18 | 繰り返されました | Raymond James | Outperform |
| 2020-04-24 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | ダウングレード | Guggenheim | Buy → Neutral |
| 2020-03-05 | 開始されました | Citigroup | Neutral |
| 2020-02-06 | 開始されました | Raymond James | Outperform |
| 2020-02-04 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | 開始されました | Guggenheim | Buy |
| 2019-10-04 | アップグレード | UBS | Neutral → Buy |
| 2019-05-17 | 繰り返されました | BofA/Merrill | Neutral |
| 2019-05-13 | 開始されました | SVB Leerink | Outperform |
| 2019-03-08 | 開始されました | BMO Capital Markets | Outperform |
| 2019-03-05 | 繰り返されました | BofA/Merrill | Neutral |
| 2019-02-27 | 繰り返されました | Lake Street | Buy |
| 2018-11-21 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | 繰り返されました | Dougherty & Company | Buy |
| 2018-09-26 | 繰り返されました | Piper Jaffray | Overweight |
すべてを表示
Tandem Diabetes Care Inc (TNDM) 最新ニュース
Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set - MassDevice
Tandem Diabetes Care gets FDA clearance for new set By Investing.com - Investing.com Nigeria
Tandem Diabetes Care gets FDA clearance for new set - Investing.com
Tandem's Initial Growth Spurt From the Launch of Mobi Should Moderate in the Near Term - Morningstar
Investor Network: Tandem Diabetes Care, Inc. to Host Earnings Call - ACCESS Newswire
INVESTOR ALERT: Levi & Korsinsky Notifies Tandem Diabetes Care, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – TNDM - ACCESS Newswire
INVESTOR ALERT: Levi & Korsinsky Notifies Tandem Diabetes Care, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineTNDM - ACCESS Newswire
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of Tandem Diabetes Care, Inc.(TNDM) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
INVESTOR ALERT: Levi & Korsinsky Reminds Tandem Diabetes Care, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 7, 2023TNDM - ACCESS Newswire
INVESTOR ALERT: Levi & Korsinsky Reminds Tandem Diabetes Care, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 7, 2023 – TNDM - ACCESS Newswire
Diabetes segment reports good news all around - BioWorld MedTech
Tandem Diabetes Care Announces Upcoming Conference Presentations - BioSpace
BlackRock, Inc. Reduces Stake in Tandem Diabetes Care Inc - GuruFocus
Insulin Pump Market Poised for 8.3% CAGR Growth Through 2033 - openPR.com
Earnings Release: Here's Why Analysts Cut Their Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Price Target To US$35.52 - simplywall.st
Tandem Diabetes jumps as overseas sales drive Q1 beat - MSN
Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates - MSN
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q1 2025 Earnings Call Transcript - Insider Monkey
TNDM Stock Rises Despite Q1 Earnings Miss, Gross Margin Up - Yahoo Finance
Tandem Diabetes Care First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Tandem Diabetes Care (TNDM): Analyst Maintains "Buy" Rating and Raises Target Price | TNDM Stock News - GuruFocus
Tandem Diabetes (TNDM) Shares Surge on Robust Q1 Revenue - GuruFocus
Tandem Diabetes Care Reports Record Sales and Strategic Growth - TipRanks
Tandem Diabetes stock jumps on Q1 results (TNDM:NASDAQ) - Seeking Alpha
Tandem Diabetes Care (TNDM) Target Price Lowered by Wells Fargo - GuruFocus
TNDM: Stifel Adjusts Price Target for Tandem Diabetes Care | TND - GuruFocus
TNDM: Piper Sandler Adjusts Price Target Amid Overweight Rating - GuruFocus
TNDM: Baird Maintains Neutral Rating, Lowers Price Target | TNDM Stock News - GuruFocus
Canaccord raises Tandem Diabetes Care target to $59 - Investing.com
Tandem Diabetes Care Stock: A Deep Dive Into Analyst Perspectives (10 Ratings) - Benzinga
Tandem Diabetes (TNDM) Sees Price Target Reduced by Baird | TNDM Stock News - GuruFocus
Tandem Diabetes (TNDM) Price Target Raised by Canaccord Amid Pro - GuruFocus
Tandem Diabetes (TNDM) Target Price Revised as Analysts Remain O - GuruFocus
Tandem Diabetes (TNDM) Price Target Adjusted by Analyst | TNDM S - GuruFocus
Tandem Diabetes Care Inc (TNDM) Q1 2025 Earnings: Revenue Surpas - GuruFocus
Tandem Diabetes Care Inc (TNDM) Q1 2025 Earnings Call Highlights: Record Sales and Strategic ... - Yahoo Finance
Tandem Diabetes Care Reports 22.3% Revenue Increase in Q1 CY2025News and Statistics - IndexBox
Tandem Diabetes Care Inc (TNDM) Q1 2025 Earnings Call Highlights - GuruFocus
Tandem's (TNDM) Strong Q1 Revenue Surpasses Expectations | TNDM Stock News - GuruFocus
Tandem Diabetes Care (TNDM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Tandem Diabetes Care Announces First Quarter 2025 Financial Results - BioSpace
Earnings call transcript: Tandem Diabetes Care Q1 2025 Misses EPS, Stock Rises - Investing.com
Tandem Diabetes’s (NASDAQ:TNDM) Q1: Beats On Revenue, Stock Soars - Yahoo Finance
Tandem Diabetes Q1 2025 slides: dual-platform strategy targets underpenetrated market - Investing.com
Tandem Diabetes (NASDAQ:TNDM) Posts Better-Than-Expected Sales In Q1, Stock Soars - Yahoo Finance
Tandem Diabetes stock surges on revenue beat, strong guidance By Investing.com - Investing.com Nigeria
Tandem Diabetes Care Inc (TNDM) 財務データ
収益
当期純利益
現金流量
EPS
0.74%
0.94%
大文字化:
|
ボリューム (24 時間):